# COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease

Study · id `cardio:ct-nct05873881` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05873881](<https://clinicaltrials.gov/study/NCT05873881>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05873881

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2500 participants.

## Technical summary

Registry record NCT05873881. Randomized; double masking; primary purpose treatment. Start 2024-01-29 (actual); primary completion 2027-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 2500 participants (planned count; ClinicalTrials.gov record NCT05873881, source copy `cardio:ctgov-nct05873881-2026-10-02`, retrieved 2026-10-26)
- Started: 2024-01-29 (actual) (ClinicalTrials.gov record NCT05873881, source copy `cardio:ctgov-nct05873881-2026-10-02`, retrieved 2026-10-26)
- Primary completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT05873881, source copy `cardio:ctgov-nct05873881-2026-10-02`, retrieved 2026-10-26)
- Completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT05873881, source copy `cardio:ctgov-nct05873881-2026-10-02`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT05873881, source copy `cardio:ctgov-nct05873881-2026-10-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05873881-2026-10-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease
- Acronym: COLT-HF
- Condition: Heart Failure
- Intervention (Drug): Colchicine 0.5 MG
- Intervention (Drug): Colchicine placebo
- Intervention (Drug): Thiamine Mononitrate 300 mg
- Lead sponsor: Hamilton Health Sciences Corporation
- Lead sponsor class: OTHER
- Collaborator: Population Health Research Institute
- Collaborator class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Hamilton Health Sciences Corporation (`cardio:org-hamilton-health-sciences-corporation`)
- Registry lists this organization as a collaborator: Population Health Research Institute (`cardio:org-population-health-research-institute`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

## Provenance

Content hash: 6eeff744c9d8b32dcdf0e142ee3f1db7003a5b4899f9090c5f970b2bfc6af997
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
